RU82209

RU82209 is an experimental small molecule drug belonging to the class of organic compounds known as dipeptides. Its chemical formula is C31H34F2N3O6P and it has a molecular weight of approximately 613.6 g/mol[1][3][4]. The compound has been studied primarily as a research tool and not for any approved therapeutic indication. Mechanistically, it acts as an inhibitor of the proto-oncogene tyrosine-protein kinase Src (Src kinase), which is involved in cell signaling pathways related to proliferation, survival, and differentiation[5]. Additionally, recent computational studies suggest that RU82209 may bind to Prohibitin 1 (PHB1) protein at ubiquitination sites and could potentially exert anti-inflammatory activity by affecting PHB1-mediated mitophagy processes[7]. However, there are no clinical trials or approved indications for this compound.

Other names

N-acetyl-N-[1-(1,1'-biphenyl-4-ylmethyl)-2-oxoazepan-3-yl]-4-[difluoro(phosphono)methyl]phenylalaninamide